Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 13, 2013 - Issue 12
Submit an article Journal homepage
237
Views
16
CrossRef citations to date
0
Altmetric
Theme: Epilepsy - Reviews

Tools for assessing quality of life in epilepsy patients

Ann JacobyDepartment of Public Health & Policy, University of Liverpool, Liverpool, L69 3GB, UKCorrespondence[email protected]
,
Gus A BakerDepartment of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK
,
Joanne CrossleyDepartment of Molecular & Clinical Pharmacology, University of Liverpool, Liverpool, UK
&
Steven SchachterHarvard Medical School, Beth Israel Deaconess Medical Centre, Boston, MA, USA
Pages 1355-1369 | Published online: 09 Jan 2014

References

  • Chung MC, Killingworth A, Nolan P. A critique of the concept of quality of life. Int. J. Health Care Qual. Assur. 10(2–3), 80–84 (1997).
  • Batzel LW, Dodrill CB, Fraser RT. Further validation of the WPSI vocational scale: comparisons with other correlates of employment in epilepsy. Epilepsia 21(3), 235–242 (1980).
  • Dodrill C, Batzel LW, Queisser HR, Temkin NR. An objective method for the assessment of psychological and social problems among epileptics. Epilepsia 21(2), 123–135 (1980).
  • World Health Organisation Quality of Life Group. What quality of life? World Health Organisation quality of life assessment. World Health Forum 17(4), 354–356 (1996).
  • Schipper H, Clinch J, Olweny CLM. Quality of life studies: definitional and conceptual issues. In: Quality of life and Pharmacoeconomics in Clinical Trials (2nd Edition). Spilker B ( Ed.). Lippincott Raven, Philadelphia, USA, 11–23 (1996).
  • Horner-Johnson W, Suzuki R, Krahn GL, Andresen EM, Drum CE. Structure of health-related quality of life among people with and without functional limitations. Qual. Life Res. 19(7), 977–984 (2010).
  • Bowling A. What things are important in people's lives? a survey of the public's judgements to inform scales of health related quality of life. Soc. Sci. Med. 41(10), 1447–1462 (1995).
  • Bowling A. The effects of illness on quality of life: findings from a survey of households in Great Britain. J. Epidemiol. Community Health, 50(6), 149–155 (1996).
  • Fisher RS, Vickrey B, Gibson P. The impact of epilepsy from the patient's perspective. I. Descriptions and subjective perceptions. Epilepsy Res. 41(1), 39–51 (2000).
  • Giovagnolia AR, Martins da Silva A, Federicoc A, Corneliod F. On the personal facets of quality of life in chronic neurological disorders. Behav. Neurol. 21(3), 155–163 (2009).
  • Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol. Assess. 2(14), (1–4) (1998).
  • Kerr MP. The impact of epilepsy on patients' lives. Acta Neurol. Scand. Suppl. 126 (Suppl.194), 1–9 (2012).
  • Beghi E, Cornaggia C. Morbidity and accidents in patients with epilepsy: results of a European cohort study. Epilepsia 43(9), 1076–1083 (2002).
  • Gaitatzis A, Johnson AL, Chadwick DW, Shorvon SD, Sander JW. Life expectancy in people with newly diagnosed epilepsy. Brain 127(Pt. 11), 2427–2432 (2004).
  • Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol. 6(8), 693–698 (2007).
  • Gaitatzis A, Trimble MR, Sander JW. The psychiatric comorbidity of epilepsy. Acta Neurol. Scand. 110(4), 207–220 (2004).
  • Kobau R, Gilliam F, Thurman DJ. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Healthstyles Survey. Epilepsia 47(11), 1915–1921 (2006).
  • Mensah SA, Beavis JM, Thapar AK, Kerr M. The presence and clinical implications of depression in a community population of adults with epilepsy. Epilepsy Behav. 8(1), 213–219 (2006).
  • Tellez-Zenteno JF, Patten SB, Jette N, Williams J, Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 48(12), 2336–2344 (2007).
  • Loring DW, Marino S, Meador KJ. Neuropsychological and behavioral effects of antiepilepsy drugs. Neuropsychol. Rev. 17(4), 413–425 (2007).
  • Baker GA, Taylor J, Aldenkamp AP, on behalf of the SANAD Group (2011). Newly diagnosed epilepsy: cognitive outcome after 12 months. Epilepsia 52(6), 1084–1091 (2011).
  • Jacoby A, Gorry J, Gamble C, Baker TA. Public knowledge, private grief: a study of public attitudes to epilepsy in the United Kingdom and implications for stigma. Epilepsia 45(11), 1405–1415 (2004).
  • Jacoby A, Gorry J, Baker GA. Employers' attitudes to employment of people with epilepsy: still the same old story? Epilepsia 46(12), 1978–1987 (2005).
  • Whatley AD, DiIorio CK, Yeager K (2010) Examining the relationships of depressive symptoms, stigma, social support and regimen-specific support on quality of life in adult patients with epilepsy. Health Educ Res. 25(4), 575–584 (2005).
  • Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 38(3), 353–362 (1997).
  • Baker GA, Hargis E, Hsih MM et al. Perceived impact of epilepsy in teenagers and young adults: an international survey. Epilepsy Behav. 12(3), 395–401 (2008).
  • Jacoby A, Baker GA, Steen N, Chadwick DW. The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia 37(2), 148–161 (1996).
  • Jacoby A, Lane S, Marson A, Baker GA, on behalf of the MESS Study Group. Relationship of clinical and quality of life trajectories following the onset of seizures: findings from the UK MESS Study. Epilepsia 52(5), 965–974 (2011).
  • Sillanpaa M, Haataja L, Shinnar S. Perceived impact of childhood-onset epilepsy on quality of life as an adult. Epilepsia 45(8), 971–977 (2004).
  • Strine TW, Kobau R, Chapman DP, Thurman DJ, Price P, Balluz LS. Psychological distress, comorbidities, and health behaviors among US adults with seizures: results from the 2002 national health interview survey. Epilepsia 46(7), 1133–1139 (2005).
  • Kobau R, Zahran H, Grant D, Thurman DJ, Price PH, Zack MM. Prevalence of Active epilepsy and health-related quality of life among adults with self-reported epilepsy in California: California Health Interview Survey, 2003. Epilepsia 48(10), 1904–1913 (2007).
  • Santhouse J, Carrier C, Arya S, Fowler H, Duncan S. A comparison of self-reported quality of life between patients with epilepsy and neurocardiogenic syncope. Epilepsia 48(5), 1019–1022 (2007).
  • Laccheo I, Ablah E, Heinrichs R, Sadler T, Baade L, Liow K. Assessment of quality of life among the elderly with epilepsy. Epilepsy Behav. 12(2), 257–261 (2008).
  • Auriel E, Landov H, Blatt I. Quality of life in seizure-free patients with epilepsy on monotherapy. Epilepsy Behav. 14(1), 130–133 (2009).
  • Elliot JO, Lu B, Shneker B, Charyton C, Moore JL. Comorbidity, health screening and quality of life among persons with a history of epilepsy. Epilepsy Behav. 14(1), 125–129 (2009).
  • Jennum P, Gyllenborg J, Kjellberg J. The social and economic consequences of epilepsy: a controlled national study. Epilepsia 52(5), 949–956 (2011).
  • Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M. Burden of epilepsy: the Ontario Health Survey. Can. J. Neurol. Sci. 26(4), 263–270 (1999).
  • Hessen E, Morten I, Lossius, LG. Health concerns predicts poor quality of life in well-controlled epilepsy. Seizure 18(7), 487–491 (2009).
  • Loring DW, Meador KJ, Lee GP. Determinants of quality of life in epilepsy. Epilepsy Behav. 5(6), 976–980 (2004).
  • Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia 52(12), 2168–2180 (2011).
  • Baker GA, Jacoby A, Buck D et al. Quality of life of older people with epilepsy: findings from a UK community study. Seizure 10(2), 92–99 (2001).
  • Pugh MJV, Copeland LA, Zeber JE et al. The impact of epilepsy on health status among younger and older adults. Epilepsia 46(11), 1820–1827 (2005).
  • Szaflarski M, Meckler JM, Privitera MD, Szaflarski JP. Quality of life in medication-resistant epilepsy: the effects of patient’s age, age at seizure onset, and disease duration. Epilepsy Behav. 8(3), 547–551 (2006).
  • Edefonti V, Bravi F, Turner K et al. Health-related quality of life in adults with epilepsy: the effect of age, age at onset and duration of epilepsy in a multicentre Italian study. BMC Neurol. 11, 33 (2011).
  • Senol V, Soyeur F, Arman F et al. Influence of fatigue, depression, and demographic, socioeconomic and clinical variables on quality of life of patients with epilepsy. Epilepsy Behav. 10(1), 96–104 (2007).
  • Rose KJ, Derry PA, Wiebe S, McLachian RS. Determinants of health-related quality of life after temporal lobe epilepsy surgery. Qual. Life Res. 5(3), 395–402 (1996).
  • Velissaris SL, Wilson SJ, Saling MM, Newton MR, Berkovic SF. The psychological impact of a newly diagnosed seizure: losing and restoring perceived control. Epilepsy Behav. 10(2), 223–233 (2007).
  • Taylor J, Jacoby A, Baker GA, Marson AG, Ring A, Whitehead M. Factors predictive of resilience and vulnerability in new-onset epilepsy. Epilepsia 52(3), 610–618 (2011).
  • Charmaz K. Loss of self: a fundamental form of suffering in the chronically ill. Sociol. Health Illn. 5(2), 168–197 (1983).
  • Arnston P, Droge D, Norton R, Murray E. The perceived psychosocial consequences of having epilepsy. In: Psychopathology in Epilepsy, Social Dimensions. Whitman S, Hermann BP ( Eds). Oxford University Press, New York, NY 143–161 (1986).
  • Marson A, Jacoby A, Kim L, Gamble C. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 365(9476), 2007–2013 (2005).
  • Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369(9566), 1000–1015 (2007).
  • Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369(9566), 1016–1026 (2007).
  • Leone MA, Beghi E, Righini C, Apolone G, Mosconi P. Epilepsy and quality of life in adults: a review of the instruments. Epilepsy Res. 66(1–3), 23–44 (2005).
  • Flanagan PJ, Beran RG. A simple validated tool for the clinician to assess psychosocial status when conducting anticonvulsant drug trials. Clin. Exp. Neurol. 21, 189–194 (1985).
  • Langfitt JT. Comparison of the psychometric characteristics of three quality of life measures in intractable epilepsy. Qual. Life Res. 4(2), 101–114 (1995).
  • Wiebe S, Rose K, Derry P, McLachlan R. Outcome assessment in epilepsy: comparative responsiveness of quality of life and psychosocial instruments. Epilepsia 38(4), 430–438 (1997).
  • Vickrey BG, Hays RD A health related quality of life instrument for patients evaluated for epilepsy surgery. Med. Care 30(4), 299–319 (1992).
  • Vickrey BG, Hays RD, Engel J Jr et al. Outcome assessment for epilepsy surgery: the impact of measuring health related quality of life. Ann. Neurol. 37(2), 158–166 (1995).
  • Devinsky O, Vickrey BG, Cramer J et al.. Development of the quality of life in epilepsy inventory. Epilepsia 36(11), 1089–1104 (1995).
  • Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann BP. Development and cross-cultural translation of a 31-item quality of life inventory (QOLIE-31). Epilepsia 39(1), 81–88 (1998).
  • Leidy NK, Elixhauser A, Vickrey B, Means E, Willian MK. Telephone validation of the quality of life in epilepsy inventory-89 (QOLIE-89). Epilepsia 40(1), 97–106 (1999).
  • Stavem K, Bjornae H, Lossius MI. Reliability and validity of a Norwegian version of the quality of life in epilepsy inventory (QOLIE-89). Epilepsia 41(1), 91–97 (2000).
  • Baker GA, Smith DF, Dewey M, Morrow J, Crawford PM, Chadwick DW. The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res. 8(3), 245–251 (1991).
  • Baker GA, Smith D, Jacoby A, Dewey M, Chadwick DW. Development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res. 16(1), 65–81 (1993).
  • 66 Baker, GA. Quality of life and epilepsy: the Liverpool experience. Clin. Ther. 20(Suppl. A), A2–A12 (1998).
  • Smith DF, Baker GA, Jacoby A, Chadwick, DW. Contribution of seizure severity to quality of life. Qual. Life Res. 4(2), 143–158 (1995).
  • Jacoby A, Baker GA, Smith DF et al. Measuring the impact of epilepsy: the development of a novel scale. Epilepsy Res. 16(1), 83–88 (1993).
  • Jacoby A (1994). Felt versus enacted stigma: a concept revisited. Soc. Sci. Med. 38(2), 261–274 (1994).
  • Rapp S, Shumaker S, Smith T, Gibson P, Berzon R, Hoffman R. Adaptation and evaluation of the Liverpool seizure severity scale and Liverpool quality of life battery for American epilepsy patients. Qual. Life Res. 7(4), 353–363 (1998).
  • Abetz L, Jacoby A, Baker GA, McNulty P. Patient-based assessments of quality of life in newly diagnosed epilepsy patients: validation of the NEWQOL. Epilepsia 41(9), 1119–1128 (2000).
  • Scott-Lennox J, Bryant-Comstock L, Lennox R, Baker GA. Reliability, validity and responsiveness of a revised scoring system for the Liverpool seizure severity scale. Epilepsy Res. 44(1), 53–63 (2001).
  • Stafford M, Gavriel S, Lloyd A. Patient-reported outcomes measurements in epilepsy. Expert Rev. Pharmacoecon. Outcomes Res. 7(4), 373–384 (2007).
  • Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Med. Care 30(6), 473–483 (1992).
  • McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item short-form health survey. II. psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31(3), 247–263 (1993).
  • Helmstaedter C, Elger CE. Cognitive-behavioural aspects of quality of life in presurgical patients with epilepsy. J. Epilepsy 7(3), 230–231 (1994).
  • Kendrick AM, Trimble MR. Repertory Grid in the assessment of quality of life in patients with epilepsy. In: Epilepsy and quality of life. Trimble MR, Dodson WE ( Eds). Raven Press, New York, NY (1994).
  • Batzel LW, Dodrill CB, Dubinsky BL et al. An objective method for the assessment of psychosocial problems in adolescents with epilepsy. Epilepsia 32(2), 202–211 (1991).
  • Wheelock I, Peterson C, Buchtel HA. Presurgery expectations, postsurgery satisfaction and psychosocial adjustment after epilepsy surgery. Epilepsia 39(5), 487–494 (1998).
  • Steinbuchel NV, Heel S, Bullinger M. A review of currently available quality of life measures. In: Quality of Life in Epilepsy: beyond seizure counts in assessment and treatment. Baker GA, Jacoby A ( Eds). Harwood Academic Press, Reading, England (2000).
  • Wiebe S, Matjevic S, Eliasziw M, Derry PA. Clinically important change in quality of life in epilepsy. J. Neurol. Neurosurg. Psychiatry 73(2), 116–120 (2002).
  • Koraliya S. Todorova, Valentina S. Velikova, Stefan T , Tsekov. Psychometric properties of the Bulgarian version of the Quality of Life in Epilepsy Inventory (QOLIE-31). Epilepsy Behav. 28(2), 203–210 (2013).
  • Gois J, Valente K, Vicentiis S et al. Assessment of psychosocial adjustment in patients with temporal lobe epilepsy using a standard measure. Epilepsy Behav. 20(1), 89–94 (2011).
  • Friedman DE, Islam S, Ettinger A. Health-related quality of life among people with epilepsy with mild seizure-related head injuries. Epilepsy Behav. 27(3), 492–496 (2013).
  • Baker GA, Smith DF, Jacoby A, Hayes JA, Chadwick DW. Liverpool seizure severity scale revisited. Seizure 7(3), 201–205 (1998).
  • Crossley J, Jacoby A, Baker GA. The reliability and validity of the revised liverpool impact of epilepsy scale for use in people with new-onset epilepsy. Epilepsy Behav. 26(2), 175–181 (2013).
  • Jacoby A, Gamble C, Doughty J, Marson A, Chadwick D. QoL outcomes of immediate versus delayed treatment of early epilepsy and single seizures. Neurology 68(15), 1188–1196 (2007).
  • Baker GA, Frances P, Middleton E. Initial development, reliability, and validity of a patient-based adverse events scale. Epilepsia 35( Suppl. 35), 80 (1994).
  • Gilliam FG, Fessler AJ, Baker G, Vahle V, Carter J, Attarian H. Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology 62(1), 23–27 (2004).
  • Perucca P, Carter J, Vahle V, Gilliam FG. Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy. Neurology 72(14), 1223–1229 (2009).
  • Perucca P, Jacoby A, Marson AG et al. Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology 76(3), 273–2809 (2011).
  • Aldenkamp AP, Baker G, Pieters MSM, Schoemaker HC, Cohen AF, Schwabe S. The Neurotoxicity Scale: the validity of a patient-based scale assessing neurotoxicity. Epilepsy Res. 20(3), 229–239 (1995).
  • Aldenkamp AP, van Meel HF, Baker GA, Brooks J, Hendriks MP. The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests. Seizure 11(4), 231–237 (2002).
  • Taylor J, Baker GA, Jacoby A. Levels of epilepsy stigma in an incident population and associated factors Epilepsy Behav. 21(3), 255–260 (2011).
  • Piazzini A, Beghi E, Turner K, Ferraroni M, the LICE Quality of Life Group. Health-related quality of life in epilepsy: findings obtained with a new Italian instrument. Epilepsy Behav. 13(1), 119–126 (2008).
  • Rao D, Choi SW, Victorson D et al. Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Qual. Life Res. 18(5), 585–595 (2009).
  • Scambler G, Hopkins A. Being epileptic: coming to terms with stigma. Soc. Health Illn. 8(1), 26–43 (1986).
  • Piazzini A, Turner K, Edefonti V, Bravi F, Canevini MP, Ferraroni M. A new Italian instrument for the assessment of irritability in patients with epilepsy. Epilepsy Behav. 21(3), 275–281 (2011).
  • Giorelli AS, Schenkel de Moura Leite Neves G, Venturi M, Monteiro Pontes I, Valois A, da Mota Gomes M. Excessive daytime sleepiness in patients with epilepsy: a subjective evaluation. Epilepsy Behav. 21(4), 449–452 (2011).
  • Hernandez-Ronquillo E, Moien-Afshari F, Knox K, Britz J, Tellez-Zenteno JF. How to measure fatigue in epilepsy? The validation of three scales for clinical use. Epilepsy Res. 95(1–2), 119–129 (2011).
  • Villanueva V, Gil-Nágel A, Elices E et al. Validation of the Spanish version of the Side Effect and Life Satisfaction Inventory in patients with epilepsy. Epilepsy Behav. 14(1), 96–101 (2009).
  • Gillham R, Baker G, Thompson P et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side effects of anti-epileptic drug treatments. Epilepsy Res. 24(1), 47–55 (1996).
  • Gillham R, Bryant-Comstock L, Kane K. Validation of the side-effect and life satisfaction (SEALS) inventory. Seizure 9(7), 458–463 (2000).
  • O’Donaghue MF, Duncan JS, Sander JW The subjective handicap of epilepsy. A new approach to measuring treatment outcome. Brain 121(pt. 2), 317–343 (1998).
  • de Almeida Monteiro E, de Lima Osório F, Veriano A Jr et al. Validation of the subjective handicap of epilepsy (SHE) in Brazilian patients with epilepsy Original Research Article. Epilepsy Behav. 24(3), 345–351 (2012).
  • Nowinski JC, Victorson D, Cavazos EJ, Gershon R, Cella D. Neuro-QOL and the NIH Toolbox: implications for epilepsy. Therapy 7(5), 533–540 (2010).
  • Gershon RC, Lai JS, Bode R et al. Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual. Life Res. 21(3), 475–486 (2012).
  • Flapper BC, Koopman HM, ten NC, van der Schans CP. Psychometric properties of the TACQOL-asthma, a disease-specific measure of health related quality-of-life for children with asthma and their parents. Chron Respir Dis. 203(2), 65–72 (2006).
  • Verhey LH, Kulik DM, Ronen GM, Rosenbaum P, Lach L, Streiner DL, the Canadian Pediatric Epilepsy Network. Quality of life in childhood epilepsy: what is the level of agreement between youth and their parents? Epilepsy Behav. 14(2), 407–410 (2009).
  • Ronen GM, Fayed N, Rosenbaum PL. Outcomes in pediatric neurology: a review of conceptual issues and recommendations. The 2010 Ronnie MacKeith Lecture. Dev. Med. Child Neurol. 53(4), 305–312 (2011).
  • Clark SA, Eiser C. The measurement of health-related quality of life (QOL) in paediatric clinical trials: a systematic review. Health Qual. Life Outcomes 2, 66 (2004).
  • De Civita M, Regier D, Alamgir AH, Anis AH, FitzGerald MJ, Marra CA. Evaluating health-related quality of life studies in paediatric populations. Pharmacoeconomics 23(7), 659–685 (2005).
  • Waters E, Davis E, Ronen GM, Rosenbaum P, Livingston M, Saigal S. Quality of Life instruments for children and adolescents with neurodisabilities: how to choose the appropriate instrument. Dev. Med. Child Neurol. 51(8), 660–669 (2009).
  • Bullinger M, Schmidt S, Petersen C. Quality of life – evaluation criteria for children with chronic conditions in medical care. J. Public Health 14(6), 343–355 (2006).
  • Landgraf JM, Abetz L, Ware JE. Child Health Questionnaire (CHQ): A Users' Manual. The Health Institute Press, MA, USA (1996).
  • Landgraf JM, Maunsell E, Speechley KN et al. Canadian-French, German and UK versions of the child health questionnaire: methodology and preliminary item scaling results. Qual. Life Res. 7(5), 433–445 (1998).
  • Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability and validity. Ambul Pediatrics 3(6), 329–341 (2003).
  • Ravens-Sieberer U, Bullinger M. Assessing the health-related quality of life in chronically ill children with the German KINDL : first psychometric and content-analytic results. Qual. Life Res. 7(5), 399–408 (1998).
  • Schmidt S, Debensason D, Mühlan H, Petersen C, Power M, Simeoni MC et al. The European DISABKIDS Group (2006) The DISABKIDS generic quality of life instrument showed cross-cultural validity. J. Clin. Epidemiol. 59(6), 587–598 (2006).
  • Schmidt S, Petersen C, Mühlan H et al. The DISABKIDS questionnaire – quality of life questionnaire for children with chronic conditions. Handbook. Pabst Science Publishers, Germany (2006b).
  • Chaplin JE, Koopman HM, Schmidt S. DISABKIDS smiley questionnaire: the TAKE 6 assisted health-related quality of life measure for 4 to 7-year-olds. Clin. Psychol. Psychother. 15(3), 173–180 (2008).
  • Cowan J, Baker GA. A review of subjective impact measures for use with children and adolescents with epilepsy. Qual. Life Res. 13(8), 1435–1433 (2004).
  • Buck D, Smith M, Appleton R, Baker GA, Jacoby A. The development and validation of the Epilepsy and Learning Disabilities Quality of Life (ELDQOL) scale. Epilepsy Behav. 10(1), 38–43 (2007).
  • Ronen GM, Streiner DL, Rosenbaum P. Health-related quality of life in children with epilepsy: development and validation of self-report and parent proxy measures. Epilepsia 44(4), 598–612 (2003).
  • Camfield C, Breau L, Camfield P. Impact of pediatric epilepsy on the family: a new scale for clinical and research use. Epilepsia 42(1), 104–112 (2001).
  • Cramer JA, Westbrook LE, Devinsky O, Perrine K, Glassman MB, Camfield C. Development of the quality of life in epilepsy inventory for adolescents: the QOLIE-AD-48. Epilepsia 40(8), 111–1121 (1999).
  • Sabaz M, Cairns DR, Lawson JA et al. Validation of a new quality of life measure for children with epilepsy. Epilepsia 41(6), 765–774 (2000).
  • Breau GM, Camfield CS, Camfield PR, Breau LM. Evaluation of the responsiveness of the impact of pediatric epilepsy scale. Epilepsy Behav. 13(3), 454–457 (2008).
  • Lv RJ, Wu LW, Jin LR, Lu Q, Wang MY, Liu H. Reliability and validity of a Chinese version of the Impact of pediatric epilepsy scale. Epilepsy Behav. 16(1), 150–155 (2009).
  • Stevanovic D. Comments on health-related quality of life measures for children and adolescents with epilepsy. Value Health 11(4), 788 (2008).
  • Haneef Z, Grant ML, Valencia I et al. Correlation between child and parental perceptions of health-related quality of life in epilepsy using the PedsQL.v4.0 measurement model. Epileptic Disord. 12(4), 275–282 (2010).
  • Taylor J, Jacoby A, Baker GA, Marson AG. Self-reported and parent-reported quality of life of children and adolescents with new-onset epilepsy. Epilepsia 52(8), 1489–1498 (2011).
  • Lai JS, Nowinski C, Victorson D, Bode R, Podrabsky T, McKinney N, Straube D et al. Quality-of-Life measures in children with neurological conditions: pediatric neuro-QOL. Neurorehabil. Neural Repair 26(1), 36–47 (2012).
  • Kobau R, Luncheon C, Zack MM, Shegog R, Price PH. Satisfaction with life domains in people with epilepsy. Epilepsy Behav. 25(4), 546–551 (2012).
  • Lundgren T, Luoma JB, Dahl J, Strosahl K, Melin L. The Bull's-Eye Values Survey: a psychometric evaluation. Cognitive Behav. Prac. 19(4), 518–526 (2012).
  • Mulhern B, Rowen D, Jacoby A et al. The development of a QALY measure for epilepsy: NEWQOL-6D. Epilepsy Behav. 24(1), 36–43 (2012).
  • Stern JM, Labiner DM, Gilliam FG et al. More effective assessment of adverse effects and comorbidities in epilepsy: results of a Phase II communication study. Epilepsy Behav. 22(3), 552–556 (2011).
  • Nilsson E, Wenemark M, Bendtsen P, Kristenson M. Respondent satisfaction regarding SF-36 and EQ-5D, and patients' perspectives concerning health outcome assessment in routine health care. Qual. Life Res. 16(10), 1647–1654 (2007).
  • Gutteling JJ, Darlington ASE, Janssen HLA, Duivenvoorden HJ, Busschbach JJV, de Man RA. Effectiveness of health-related quality of life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians. Qual. Life Res. 17(2), 195–205 (2008).
  • Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual. Life Res. 17(2), 175–193 (2008).
  • Beeken RJ, Eiser C, Dalley C. Health-related quality of life in haematopoietic stem cell transplant survivors: a qualitative study on the role of psychosocial variables and response shifts. Qual. Life Res. 20(2), 153–160 (2011).
  • Donohoe JE. To what extent can response shift theory explain the variation in prostate cancer patients’ reactions to treatment side-effects? A review. Qual. Life Res. 20(2), 161–167 (2011).
  • Wilson SJ, Saling MM, Kincade P, Bladin PF. Patient expectations of temporal lobe surgery. Epilepsia 39(2), 167–174 (1998).
  • Ring L, Gross CR, McColl E. Putting the text back into context: toward increased use of mixed methods for quality of life research. Qual. Life Res. 19(5), 613–615 (2010).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.